Cardiovascular Risks and Benefits of Medications Used for Weight Loss.

Bramante, Carolyn T; Raatz, Sarah; Bomberg, Eric M; Oberle, Megan M; Ryder, Justin R

Bramante, Carolyn T; Raatz, Sarah; Bomberg, Eric M; Oberle, Megan M; Ryder, Justin R.

Afiliação

Bramante CT; Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.
Raatz S; Division of General Internal Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.
Bomberg EM; Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.
Oberle MM; Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.
Ryder JR; Division of Pediatric Endocrinology, University of Minnesota Medical School, Minneapolis, MN, United States.

Front Endocrinol (Lausanne) ; 10: 883, 2019.

Article em En | MEDLINE | ID: mdl-32010059

Palavras-chave

anti-obesity agents; blood pressure; cardiovascular diseases; diabetes mellitus type 2; obesity; obesity therapy; pediatric obesity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google